How many drugs treat Nongonococcal urethritis?

Drug Landscape tracks 5 marketed treatments for Nongonococcal urethritis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/nongonococcal-urethritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Nongonococcal urethritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nongonococcal urethritis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Nongonococcal urethritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vibramycin	doxycycline	Generic (originally Pfizer)	Tetracycline antibiotic	72 kDa type IV collagenase, Stromelysin-1, Collagenase 3	1967-01-01
Benzamycin	Erythromycin Lactobionate	Pfizer	Macrolide	Potassium voltage-gated channel subfamily H member 2	1964-01-01
E-Mycin	erythromycin	Generic (originally Abbott/Lilly)	Macrolide [EPC]	Aldehyde oxidase, Bile salt export pump, Cytochrome P450 1B1	1952-01-01
Doxycyclin	Doxycyclin	Bulovka Hospital		72 kDa type IV collagenase, Stromelysin-1, Collagenase 3
Ofloxacine	Ofloxacine	Assistance Publique - Hôpitaux de Paris		Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Nongonococcal urethritis
Assistance Publique - Hôpitaux de Paris · 1 drug in Nongonococcal urethritis
Bulovka Hospital · 1 drug in Nongonococcal urethritis
Generic (originally Abbott/Lilly) · 1 drug in Nongonococcal urethritis
Generic (originally Pfizer) · 1 drug in Nongonococcal urethritis
Pfizer · 1 drug in Nongonococcal urethritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Nongonococcal urethritis:

Cite this brief

Drug Landscape (2026). Nongonococcal urethritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/nongonococcal-urethritis. Accessed 2026-06-10.

Nongonococcal urethritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing